Table 3.

Characteristics of the groups evaluated in the FCCA adsorption experiments.

				Age			Time to Last Event # (days)
Group	Type of SARS-CoV-2 Exposure	Individuals (n)	Female (%)	Range	Mean	SD **	Range	Median
D2 *	3X mRNA Vaccinated	6	3 (50)	23–45	34	7	20–50	29
E *	3X Vaccinated + Omicron breakthrough	6	3 (50)	23–43	32	7	23–47	26

* Sub-groups of the parent cohorts in Table 1; ^** Standard deviation; ^# Event refers to vaccination or infection; Inclusion criterium was ≥20 days since last exposure by infection/vaccination. Notably, all sera were drawn from the subjects prior to the approval of bivalent-adapted mRNA vaccines by the European Medicines Agency (EMA) and subjects are therefore likely to have received only the monovalent mRNA vaccine.